Marshall Wace, LLP Incyte Corp Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Incyte Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 291,701 shares of INCY stock, worth $17.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

291,701

Previous 42,659 583.8%

Holding current value

$17.7 Million

Previous $2.68 Million 520.54%

% of portfolio

0.03%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $14.1 Million - $16.6 Million	249,042 Added 583.8%	291,701 $16.6 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $28.5 Million - $35.1 Million	-546,865 Reduced 92.76%	42,659 $2.68 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $25.7 Million - $29.3 Million	444,439 Added 306.33%	589,524 $34.1 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $2.32 Million - $2.87 Million	-38,005 Reduced 20.76%	145,085 $9.03 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $5.88 Million - $7.2 Million	-83,722 Reduced 31.38%	183,090 $13.2 Million

Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $14.7 Million - $18.4 Million	219,012 Added 458.18%	266,812 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $3.16 Million - $3.96 Million	47,800 New	47,800 $3.19 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $27 Million - $32.6 Million	-408,989 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $23.1 Million - $27.1 Million	365,425 Added 838.82%	408,989 $30 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $2.12 Million - $2.59 Million	30,850 Added 242.65%	43,564 $3 Million
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $6.58 Million - $7.22 Million	-82,440 Reduced 86.64%	12,714 $1.07 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $7.23 Million - $9.56 Million	95,154 New	95,154 $7.73 Million
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $4,821 - $7,080	-65 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $2.03 Million - $2.77 Million	-32,176 Reduced 99.8%	65 $5,000
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $4.49 Million - $5.88 Million	-61,470 Reduced 65.6%	32,241 $2.82 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $4.82 Million - $5.72 Million	66,132 Added 239.79%	93,711 $6.96 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $831,952 - $1 Million	11,316 Added 69.58%	27,579 $2.34 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $1.03 Million - $1.43 Million	16,263 New	16,263 $1.4 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $2.12 Million - $2.53 Million	-36,209 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $2.24 Million - $2.69 Million	36,209 New	36,209 $2.5 Million

Others Institutions Holding INCY

# of Institutions

617

Shares Held

215M

Call Options Held

366K

Put Options Held

445K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Incyte Corp Transaction History